Life Spine announced that it won additional FDA clearance to market its Lateral ProLift expandable system as it prepares to launch 20 new products in 2020.
The Lateral ProLift system is designed to offer a micro-invasive solution for lateral lumbar interbody fusions, minimizing impaction, preserving end-plate integrity and maximizing indirect compression, according to the company’s website.
It features minimal insertion height and controlled in situ expansion, which are critical components in a minimally invasive expandable lateral interbody fusion procedure. The Lateral ProLift system initially won FDA 510(k) clearance in June 2019.
Life Spine’s current expandable portfolio consists of six systems for approaches including transforaminal lumbar interbody fusion (TLIF) and posterior lumbar interbody fusion (PLIF). In a news release, Life Spine COO Rich Mueller said the company plans to increase its expandable device tally to 13 as it’s slated to launch those 20 new products this year.
“Investing in expandable technologies is important to us because expandables are designed to allow for a truly micro-invasive procedure by going in small and opening to match each patient’s unique anatomy,” Mueller said. “Our dedication to offering expandable solutions dates back to 2006 when we filed our first patent around expandable technology and now we aim to file one patent each month.”
